Cargando…
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
BACKGROUND: The clinical significance of intratumoral human epidermal growth factor receptor 2 (HER2) heterogeneity is unclear for HER2-positive gastric cancer, although it has been reported to be a significant prognosticator for HER2-positive breast cancer, which has received trastuzumab-based chem...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695545/ https://www.ncbi.nlm.nih.gov/pubmed/31423428 http://dx.doi.org/10.12998/wjcc.v7.i15.1964 |